  |
Market Research in the Healthcare Field with Expertise in Medical Imaging and Radioisotopes
Bio-Tech Systems, Inc. - 4167 West Pinecrest Circle - Las Vegas, Nevada 89121 phone: (702) 456-7608 - fax: (702) 456-2189
THE U.S. MARKET FOR BRACHYTHERAPY PRODUCTS |
|
BIO-TECH SYSTEMS INC. announces the publication of: BIO-TECH Report #290, The U.S. Market for Brachytherapy Products The Brachytherapy Report Includes:
The report also examines the continuing prospects for endovascular brachytherapy, the market for brain cancer brachytherapy and other post-surgical applications, such as head and neck cancer, skin cancer, colorectal cancer esophageal cancer and various cancers accessible to brachytherapy as well as ophthalmic brachytherapy for intraocular tumors. The report considers the trade-offs between LDR (low dose rate) and HDR (high dose rate) brachytherapy, the integration of brachytherapy with other treatment modalities and the increasing number of options available to both clinicians and patients as new technology enters the mainstream. The report has a strong focus on new products and technology and emerging market opportunities. Many new brachytherapy products have been introduced recently, with rapid growth in procedure volume. This has provided a good opportunity for evaluating performance and forecasting future growth. There are also a number of new products and technologies on the threshold, with introduction anticipated in the near future. This will stimulate further growth and encourage wider acceptance of brachytherapy with improved outcomes for many patients. A number of entrepreneurial companies have entered the field with new technology and products that have strong market potential. One of the most promising is brachytherapy for macular degeneration where the incidence and prevalence of disease is very high. Brachytherapy coupled with new drugs that restrict vascular growth in tumors will allow sustained benefit for many patients. These developments are prompting investment in new technology, creating a good platform for future growth. Brachytherapy Market Analysis and Future Prospects US sales of brachytherapy products were $240 million in 2008 and should grow to $1,979 million by 2016. Implantable prostate seeds were the largest market segment with sales of $121.5 million in 2008, comprising 51% of total brachytherapy sales. This proportion will diminish in the future as other brachytherapy market segments grow more rapidly. By 2016, prostate seed sales will comprise only 6.5% of total brachytherapy sales. This market has been under pressure from competing modalities, such as IMRT (intensity modulated radiation therapy) and robotic microsurgery. Many men have also become better educated with respect to prostate cancer and are evaluating their options more carefully, including watchful waiting. Other important brachytherapy market segments are partial breast irradiation with sales of $41.7 million in 2008. This should increase to $358.9 million by 2016. Also, sales of irradiated microspheres for liver cancer were $47.9 million in 2008 and this should increase to $236.8 million by 2016. The market for gynecological brachytherapy, which was just on the threshold in 2008, should grow to $32.5 million, which is a conservative estimate considering the incidence of cervical and uterine cancer and benefits of brachytherapy in this area. The most rapid market growth will be in treating macular degeneration. This technology has been successfully demonstrated and the first product will be introduced in 2010. The primary product in development has already been awarded CE approval in Europe and should receive FDA approval in the U.S. fairly soon. There are over 2 million cases of macular degeneration in the U.S. with 220,000 newly diagnosed cases each year. Brachytherapy in this area will generate rapid sales growth that should reach $1,170 million by 2016. This will help all segments of brachytherapy, expanding the platform for new products. One effect is that clinicians will have more options as alternatives to higher risk and more costly procedures. This will stimulate more research and investment, adding strength and stability to newer venture companies as well as those more established in the field. Please follow one of the links below, or on the left, to find out more information about BIO-TECH Report #290. If you are interested in purchasing BIO-TECH Report #290, please follow this link to our Online Order Form. To download a detailed Table of Contents (TOC) for BIO-TECH Report #290, please click on one of the two links below. The documents are a Microsoft Word 97-2000 file and an Adobe Acrobat 6 PDF file.  Download TOC in MS Word format (124KB) Download TOC in Adobe PDF format (45KB) |
Back to Top| Report Contents | Partial List of Exhibits |
| Report #290 Home Page |
|
Download Report #290 Table of Contents: BTSI290.doc
-OR-
BTSI290.pdf
|
Send
this page to a friend
Breaking Market News | Orders | News Releases | Contact Us
Report #310 | Report #300 | Report #290 | Report #260 | Report #230 | Top